Author:
Doležel Martin,Hartmann Igor,Odrážka Karel,Vaňásek Jaroslav,Vlachová Zuzana
Reference33 articles.
1. Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER Program
2. A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden
3. A 10-Year Retrospective Review of a Nonrandomized Cohort of 458 Patients Undergoing Radical Radiotherapy or Cystectomy in Yorkshire, UK
4. Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation
5. International collaboration of trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-Urinary Group, Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, Club Urologico Espanol de Tratamiento Oncologico (CUETO) group. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists;Lancet,1999